Bengaluru: The country's first human gene therapy trial for haemophilia was conducted through a collaboration between ...

While haemophilia and VWD are both inherited bleeding disorders they differ significantly Being a rare disease haemophilia is ...

This World Hemophilia Day, global focus shifts to the often-overlooked struggles of women with haemophilia, calling for ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

World Haemophilia Day is celebrated on 17th April every year and is a genetic blood disorder where the blood does not clot ...

Haemophilia is a genetic bleeding disorder that occurs rarely due to deficiencies in clotting factors, leading to unheeded or ...

Haemophilia is a genetic bleeding disorder caused by mutations in the genes that produce clotting factor VIII or factor IX, ...

Some families are forced to go without the best care  - simply because they can’t afford it.”A Silent Condition with Loud ...

Suraj (name changed), 11, dreams of becoming a scientist when he grows up. However, his goal seemed like a distant dream as ...

Pfizer’s Hympavzi (marstacimab) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...

Union Minister Dr Jitendra Singh on Thursday inspected various facilities at the BRIC-inStem facility and reviewed ongoing ...